ARTICLE | Clinical News
The Liposome regulatory update
January 17, 1994 8:00 AM UTC
The Princeton, N.J., company said it filed marketing applications for ABLC amphotericin B lipid complex in six European countries and plans to file for marketing approval in 10 additional European countries this year. ABLC is the first drug for which the company has filed for marketing approval. ...